a 63162 has been researched along with 1-naphthylisothiocyanate in 1 studies
| Studies (a 63162) | Trials (a 63162) | Recent Studies (post-2010) (a 63162) | Studies (1-naphthylisothiocyanate) | Trials (1-naphthylisothiocyanate) | Recent Studies (post-2010) (1-naphthylisothiocyanate) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 414 | 0 | 142 |
| Protein | Taxonomy | a 63162 (IC50) | 1-naphthylisothiocyanate (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 1 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 6.272 | |
| Adenosine receptor A3 | Homo sapiens (human) | 6.1 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 6.1 | |
| C-C chemokine receptor type 2 | Homo sapiens (human) | 6.699 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 6.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailie, MB; Carter, GW; Dahm, LJ; Harris, RR; Peters-Golden, M; Roth, RA | 1 |
1 other study(ies) available for a 63162 and 1-naphthylisothiocyanate
| Article | Year |
|---|---|
Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
Topics: 1-Naphthylisothiocyanate; Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione; Hydroxyurea; Indoles; Inflammation; Leukotriene Antagonists; Leukotrienes; Lipoxygenase Inhibitors; Liver; Liver Diseases; Male; Phenyl Ethers; Rats; Rats, Sprague-Dawley | 1995 |